Melatonin Market Report 2026

The melatonin market size has grown strongly in recent years. It will grow from $2.03 billion in 2025 to $2.2 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing prevalence of sleep disorders, rising stress and lifestyle imbalance, expansion of dietary supplement consumption, greater awareness of circadian rhythm health, availability of otc melatonin products.

The melatonin market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for personalized sleep solutions, rising focus on mental wellness, expansion of e-commerce supplement sales, growing acceptance of preventive healthcare, increasing research into sleep health. Major trends in the forecast period include increasing demand for natural sleep aids, rising adoption of otc sleep supplements, growing preference for non-habit forming solutions, expansion of multiple dosage formats, enhanced focus on circadian health.

The increasing prevalence of insomnia is expected to drive the growth of the melatonin market in the coming years. Insomnia is a sleep disorder characterized by difficulty falling asleep, staying asleep, or waking up too early without being able to return to sleep, despite having the opportunity to rest. The rise in insomnia cases is attributed to factors such as heightened stress levels, excessive screen time, irregular sleep patterns, aging populations, and a growing incidence of chronic health conditions. Melatonin is effective in treating insomnia as it helps regulate the body’s sleep-wake cycle, facilitating easier sleep onset and maintenance, particularly in cases involving circadian rhythm disruptions. For instance, in April 2024, according to Oxford University Press, a UK-based publishing company, approximately 19.5% of adult females and 14% of adult males in the Americas were affected by insomnia in 2024, totaling around 123 million people. Therefore, the growing prevalence of insomnia is propelling the growth of the melatonin market.

Key companies in the melatonin market are concentrating on developing innovative technologies, such as three-in-one tablet-in-capsule systems, to enhance controlled release, improve absorption efficiency, and provide extended sleep support for better consumer outcomes. Three-in-one tablet-in-capsule technology encapsulates three tablets within a single capsule, releasing ingredients at different intervals to optimize absorption and deliver more effective and convenient treatment. For instance, in September 2023, Ritual, a US-based wellness company, launched a new melatonin supplement featuring its BioSeries technology, a three-phase release system within a single capsule, which delivers melatonin in stages to align with the body’s natural sleep-wake cycle. This technology improves sleep quality by promoting faster sleep onset, sustaining restful sleep, and ensuring a refreshed feeling upon waking.

In May 2023, Adalvo Limited, a Malta-based pharmaceutical company, partnered with EQL Pharma to expand the global commercialization of Mellozzan, a melatonin-based product. Through this collaboration, Adalvo leverages its regulatory expertise and distribution network across 89 countries, while EQL Pharma focuses on manufacturing and supply. EQL Pharma is a Sweden-based pharmaceutical company specializing in the development, marketing, and sale of generic and specialty medicines.

Major companies operating in the melatonin market are Church and Dwight Co Inc, Herbalife Nutrition Ltd, Zenith Nutrition, Amway Corporation, Aurobindo Pharma, Aspen Holdings, Nu Skin Enterprises Inc, GNC Holdings LLC, Pharmavite LLC, Jamieson Wellness Inc, Rexall Sundown Inc, Natures Way Brands LLC, Schiff Nutrition International, Natrol LLC, Solgar Inc, Biotics Research Corporation, Herbaland Naturals Inc, Lactonova Nutripharm Pvt Ltd, Prime Health Ltd, Nestle Health Science, Bayer Consumer Health, Abbott Nutrition.

North America was the largest region in the melatonin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the melatonin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the melatonin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the melatonin market by increasing costs of imported raw materials, synthetic intermediates, encapsulation materials, and packaging components used in supplement and pharmaceutical production. North America and Europe are most affected due to dependence on imported active ingredients, while Asia-Pacific faces cost pressure on bulk manufacturing and exports. These tariffs are raising product prices and affecting supply consistency. However, they are also supporting domestic ingredient sourcing, local manufacturing investments, and innovation in plant-based and alternative melatonin formulations.

The melatonin market research report is one of a series of new reports that provides melatonin market statistics, including melatonin industry global market size, regional shares, competitors with a melatonin market share, detailed melatonin market segments, market trends and opportunities, and any further data you may need to thrive in the melatonin industry. This melatonin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Melatonin is a natural hormone produced by the pineal gland in the brain that helps regulate the body’s sleep-wake cycle, also known as the circadian rhythm. It is commonly used in supplement form to support sleep, particularly for conditions such as insomnia or jet lag, by signaling to the body that it is time to rest.

The primary types of melatonin include natural and synthetic forms. Natural melatonin, produced by the pineal gland, can also be derived from natural extracts for use in supplements. Melatonin products are available in various formats, including tablets, capsules, liquid solutions, gummies, and sublingual tablets. Treatments may involve dietary supplements and, in certain cases, pharmaceuticals. Melatonin is used to manage insomnia, jet lag, sleep disorders, stress reduction, and regulation of circadian rhythms. These products are widely distributed through online retailers, pharmacies, health food stores, supermarkets, hypermarkets, and specialty stores.

The melatonin market consists of sales of patches, sprays, combination sleep aids, and lozenges. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.